Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) can cause sweating in some people, though it is not listed among the most common side effects in the licensed prescribing information. Sweating tends to arise indirectly, driven by the body changes that accompany early treatment: shifts in blood glucose, the body working harder during digestion, or simply the physical response to nausea. If you have noticed increased sweating since starting tirzepatide, you are far from alone, and in most cases there is a straightforward explanation. These are prescription-only medicines, assessed individually by a clinician, and any symptom that concerns you is worth raising with your prescriber. The NHS patient information for tirzepatide is a reliable starting point for checking which effects are expected and which warrant prompt attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first practical thing to do takes under a minute: note the time of day the sweating occurs relative to your dose. Mounjaro is injected once weekly, but its effects on digestion and appetite (and its indirect influence on blood glucose) play out across the whole week. Sweating that clusters in the 24–48 hours after your injection is most likely tied to the peak of the medicine's activity on your gut, particularly if you also feel nauseated or have loose stools during that window.
Sweating that happens at night, regardless of when you inject, follows a different pattern. The body's glucose regulation shifts subtly on tirzepatide, and for some people the overnight period brings mild hypoglycaemic episodes, not dangerous in most non-diabetic patients, but enough to trigger the sympathetic nervous response that produces sweating, clamminess and a racing heart. There is more on this specific pattern on the night sweats and Mounjaro page.
Daytime sweating that is diffuse and unrelated to meals or dose timing is less clearly explained by tirzepatide's direct mechanism. In those cases it is worth telling your prescriber, because unrelated causes should not be dismissed just because you are on a new medicine.
Tirzepatide works as a dual GIP and GLP-1 receptor agonist, activating two gut-hormone pathways that slow gastric emptying and reduce appetite. That gastric-slowing effect is efficient at reducing how much you eat, but it also means digestion is more effortful, and the body generates more heat in the process. Sweating as a thermoregulatory response to that extra digestive work is the most benign explanation, and it usually eases as your gut adapts over several weeks.
The second mechanism is blood glucose fluctuation. Even in people without diabetes, tirzepatide's action on insulin secretion can cause glucose to dip lower than usual, particularly after meals or overnight. The body's counter-regulatory response to a falling glucose level includes adrenaline release, and adrenaline causes sweating. If you notice the sweating accompanies shakiness, light-headedness or sudden hunger, that cluster of symptoms is worth flagging to your prescriber the same day.
The third is straightforward weight loss itself. As body composition changes over weeks of treatment, some people find their baseline temperature regulation shifts. Fat tissue is metabolically active and insulating; losing it changes how your body handles heat. You can read more about the reasons tirzepatide can cause sweating and how the symptom typically develops on our dedicated page, as well as the broader biochemical effects of tirzepatide on the full range of what Mounjaro does beyond appetite suppression page.
Most sweating on Mounjaro is uncomfortable rather than dangerous. The signs that it has crossed into territory requiring prompt medical input are: sweating combined with confusion or difficulty thinking clearly; palpitations or a pounding heartbeat; trembling or shakiness; pallor or sudden weakness. These are the classic features of significant hypoglycaemia and need same-day assessment, not watchful waiting.
Severe, persistent stomach pain radiating to the back (with or without sweating) is a separate concern. The MHRA's January 2026 Drug Safety Update flagged acute pancreatitis as an infrequent but potentially serious effect of GLP-1 medicines; that pain pattern, sweating included, should prompt urgent medical contact. You can report any suspected side effect through the MHRA Yellow Card scheme.
If you are on tirzepatide for weight management alongside type 2 diabetes treatment, your glucose monitoring records are your best guide. Bring them to any prescriber conversation about sweating episodes.
A few straightforward changes make a genuine difference for most people. Staying well hydrated reduces the intensity of GI-related sweating; tirzepatide-related nausea and loose stools can cause mild dehydration, which itself makes you sweat more efficiently at lower exertion. Eating protein-led, lower-glycaemic meals (an approach covered in detail on the what to eat on Mounjaro page) helps keep glucose levels steadier, which directly reduces the frequency of the glucose-dip sweating episodes.
Timing your dose on a day when you can rest more in the 24 hours after injection is a practical option some people find helpful, particularly if the post-dose digestive response is their main trigger. Wearing breathable fabrics and keeping your bedroom cooler addresses the symptom rather than the cause, but there is nothing wrong with that while your body adjusts.
If the sweating is significant or persistent beyond the first four to six weeks of a dose level, a conversation with your prescriber is warranted before assuming it is just adaptation. The Mounjaro treatment overview explains the full dose titration process and what to expect at each stage. For a broader look at weight management options assessed by our clinical team, the weight loss treatments page covers the full picture. And if you have questions about cost as you plan ahead, the Eli Lilly UK price increase page sets out the current context honestly.
If you are considering starting tirzepatide or want a clinical view on symptoms you are experiencing, our prescribers are available seven days a week. Start your free consultation and a GPhC-registered prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.